Feds Seek To Weigh In On Pfizer Exec's 1st Circ. FCA Appeal

Law360, Los Angeles (April 2, 2012, 9:57 PM EDT) -- The U.S. on Friday asked the First Circuit to let it participate in oral arguments in an appeal attempting to revive an ex-Pfizer Inc. executive's False Claims Act suit accusing the drugmaker of paying kickbacks to doctors who prescribed its human growth hormone drug Genotropin.

“The United States has a substantial interest in the proper interpretation of the False Claims Act because it is the government's primary tool to combat fraud and recover losses from fraud in federal contracts and programs,” the government said in a...
To view the full article, register now.